by Ruchi Mallya
The cost and time associated with bringing a new blockbuster drug to market is reaching astronomical heights – an average of $1 billion over 12 years…read more

(Source: Datamonitor) Having demonstrated its potential in the transport sector, Tessella has outlined plans to launch a predictive analytics tool for the utilities industry. While Ovum believes this to be a sensible move based on the opportunities that smart grid initiatives will offer predictive analytics vendors, it remains to be seen whether Tessella has the [...]

Two Drug Information Journal articles on planning and executing response adaptive clinical trials state savings of 2 to 5 months and $1 million to $14 million when using adaptive trials versus using more traditional designs. The Journal’s articles are available on-line: article one - The Process page 710 and article two - Case Studies page 725

Long known for its scientific software delivery expertise and technical staffing capability, Tessella is mounting a push to climb higher up the consultancy ladder…read more

Stephen Mounsey finds out about the computing power behind some of the world’s most ambitious scientific projects…read more

Wyeth Research and partners are developing trial simulation software to streamline the process of designing and running adaptive clinical trials (ACTs)…read more on page 25

Greg Blackman looks at some of the current trends taking place in the pharmaceutical industry with regards to data management…read more

Wyeth Research brought home this year’s Bio-IT World Best Practices Award in the Clinical Trial Design category…read more

April 29, 2009 | BOSTON – Bio-IT World announced the winners of its fifth annual Best Practices Awards program at a gala dinner last night at the World Trade Center in Boston, site of the 2009 Bio-IT World Conference & Expo…read more

Getting to grips with digital content and its preservation raises huge issues for libraries and other repositories…read more